BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 19536100)

  • 1. Open access chemical and clinical probes to support drug discovery.
    Edwards AM; Bountra C; Kerr DJ; Willson TM
    Nat Chem Biol; 2009 Jul; 5(7):436-40. PubMed ID: 19536100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Precompetitive consortia in biomedicine--how are we doing?
    Mittleman B; Neil G; Cutcher-Gershenfeld J
    Nat Biotechnol; 2013 Nov; 31(11):979-85. PubMed ID: 24213770
    [No Abstract]   [Full Text] [Related]  

  • 3. Precompetitive activity to address the biological data needs of drug discovery.
    Sidders B; Brockel C; Gutteridge A; Harland L; Jansen PG; McEwen R; Michalovich D; Seidel H; Weiss B; Williams-Jones B; Woodwark M
    Nat Rev Drug Discov; 2014 Feb; 13(2):83-4. PubMed ID: 24481293
    [No Abstract]   [Full Text] [Related]  

  • 4. Mads Krogsgaard Thomsen. Interview by Asher Mullard.
    Thomsen MK
    Nat Rev Drug Discov; 2014 Feb; 13(2):96-7. PubMed ID: 24481301
    [No Abstract]   [Full Text] [Related]  

  • 5. David Haslam. Interview by Asher Mullard.
    Haslam D
    Nat Rev Drug Discov; 2013 Jul; 12(7):500. PubMed ID: 23764976
    [No Abstract]   [Full Text] [Related]  

  • 6. [Dismantling of "Big Pharma" gives new impetus to the pharmaceutical sector. Dynamic life science clusters can increase Swedish competitiveness].
    Hedner T; Gatenbeck L
    Lakartidningen; 2012 Jun 27-Jul 17; 109(26-28):1280-1. PubMed ID: 22852257
    [No Abstract]   [Full Text] [Related]  

  • 7. Competition: Unlikely partnerships.
    Savage N
    Nature; 2016 May; 533(7602):S56-8. PubMed ID: 27167391
    [No Abstract]   [Full Text] [Related]  

  • 8. Q&A: Bernard Munos.
    Bender E
    Nature; 2016 May; 533(7602):S59. PubMed ID: 27167392
    [No Abstract]   [Full Text] [Related]  

  • 9. Precompetitive research: a new prescription for drug development?
    Woodcock J
    Clin Pharmacol Ther; 2010 May; 87(5):521-3. PubMed ID: 20407454
    [No Abstract]   [Full Text] [Related]  

  • 10. The interface between publicly funded and industry-funded research in pediatric psychopharmacology: opportunities for integration and collaboration.
    Vitiello B; Heiligenstein JH; Riddle MA; Greenhill LL; Fegert JM
    Biol Psychiatry; 2004 Jul; 56(1):3-9. PubMed ID: 15219466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug discovery: new models for industry-academic partnerships.
    Tralau-Stewart CJ; Wyatt CA; Kleyn DE; Ayad A
    Drug Discov Today; 2009 Jan; 14(1-2):95-101. PubMed ID: 18992364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Setbacks in Alzheimer research demand new strategies, not surrender.
    Jobke B; McBride T; Nevin L; Peiperl L; Ross A; Stone C; Turner R;
    PLoS Med; 2018 Feb; 15(2):e1002518. PubMed ID: 29486005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Into the valley of death: research to innovation.
    Hudson J; Khazragui HF
    Drug Discov Today; 2013 Jul; 18(13-14):610-3. PubMed ID: 23402848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promoting drug discovery by collaborative innovation: a novel risk- and reward-sharing partnership between the German Cancer Research Center and Bayer HealthCare.
    Wellenreuther R; Keppler D; Mumberg D; Ziegelbauer K; Lessl M
    Drug Discov Today; 2012 Nov; 17(21-22):1242-8. PubMed ID: 22521665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How informatics can potentiate precompetitive open-source collaboration to jump-start drug discovery and development.
    Perakslis ED; Van Dam J; Szalma S
    Clin Pharmacol Ther; 2010 May; 87(5):614-6. PubMed ID: 20376001
    [No Abstract]   [Full Text] [Related]  

  • 16. Novelty in the target landscape of the pharmaceutical industry.
    Agarwal P; Sanseau P; Cardon LR
    Nat Rev Drug Discov; 2013 Aug; 12(8):575-6. PubMed ID: 23903214
    [No Abstract]   [Full Text] [Related]  

  • 17. Tropical disease: A neglected cause.
    Laursen L
    Nature; 2016 May; 533(7602):S68-9. PubMed ID: 27167396
    [No Abstract]   [Full Text] [Related]  

  • 18. Partnering for therapeutics discovery.
    Colvis CM; Devaney S; Brady LS; Hudson KL
    Clin Pharmacol Ther; 2013 Jan; 93(1):24-5. PubMed ID: 23187876
    [No Abstract]   [Full Text] [Related]  

  • 19. A bitter pill.
    Nat Chem; 2010 May; 2(5):337. PubMed ID: 20414223
    [No Abstract]   [Full Text] [Related]  

  • 20. A lesson from Japan: research and development efficiency is a key element of pharmaceutical industry consolidation process.
    Shimura H; Masuda S; Kimura H
    Drug Discov Ther; 2014 Feb; 8(1):57-63. PubMed ID: 24647159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.